Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment

Genetics in Medicine

Volumn 9, Issue 5, 2007, Pages 275-282

  MacDonald, Deborah J ^a   Sarna, Linda ^b   Van Servellen, Gwen ^b   Bastani, Roshan ^c   Giger, Joyce Newman ^b   Weitzel, Jeffrey N ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cancer risk communication; Communication barriers; Family communication; Genetic counseling

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CHI SQUARE TEST; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC RISK; HEALTH SURVEY; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MCNEMAR TEST; OVARY CANCER; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

ADULT; AGED; COMMUNICATION BARRIERS; DISCLOSURE; FAMILY; FEMALE; GENETIC SCREENING; HUMANS; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; RISK ASSESSMENT; SEX FACTORS;

EID: 34249014374     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e31804ec075     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Murray T, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-130.
2. Ziogas A, Gildea M, Cohen P, Bringman D, et al. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9 (1):103-111.
3. Narod SA, Olsson H. Risk of ovarian cancer in breast-cancer patients with a family history of either. Lancet 2003;361:(9352):179; author reply 179-180.
4. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994;73:643-651.
5. NIH Consensus Conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 1995;273:491-497.
6. Ford D, Easton DF, Stratton M, Narod S, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-689.
7. Struewing JP, Hartge P, Wacholder S, Baker SM, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336 (20):1401-1408.
8. Metcalfe K, Lynch HT, Ghadirian P, Tung N, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004;22 (12):2328-2335.
9. Metcalfe KA, Lynch HT, Ghadirian P, Tung N, et al. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 2005;96 (1):222-226.
10. Greco KE, Mahon SM. Genetics nursing practice enters a new era with credentialing. The Internet Journal of Advanced Nursing Practice 2003;5(2). Available at: http://www.ispub.com/ostial/index.php?xmlFilePath= journals/jhan/front.xml. Accessed April 6, 2007.
11. International Society of Nurses in Genetics I. Statement on the scope and standards of genetics clinical nursing practice. Washington, DC: American Nurses Publishing, 1998.
12. MacDonald DJ, Sand S, Kass FC, Blazer KR, et al. The power of partnership: extending comprehensive cancer center expertise in clinical cancer genetics to breast care in community centers. Semin Breast Dis in press.
13. American Society of Human Genetics. Professional disclosure of familial genetics information. Am J Hum Genet 1998;62:474-483.
14. ASCO. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:(12):2397-2406.
15. Offit K, Groeger E, Turner S, Wadsworth EA, et al. The "duty to warn" a patient's family members about hereditary disease risks. JAMA 2004;292 (12):1469-1473.
16. Keeling SL. Duty to warn of genetic harm in breach of patient confidentiality. J Law Med 2004;12 (2):235-253.
17. Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002;70 (3):784-797.
18. MacDonald DJ. Ethical, legal, and social issues related to predisposition testing for breast cancer risk: what nurses need to know. Quality of Life-A Nursing Challenge 1997;6:8-14.
19. MacDonald DJ. Genetic predisposition testing for cancer: effects on families' lives. Holist Nurs Pract 1998;12 (3):9-19.
20. Kenen R, Arden-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC). Psychooncology 2004;13 (5):335-345.
21. Sermijn E, Goelen G, Teugels E, Kaufman L, et al. The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet 2004;41 (3):E23.
22. McGivern B, Everett J, Yager GG, Baumiller RC, et al. Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 2004;6 (6):503-509.
23. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A 2003;116 (1):11-19.
24. Costalas JW, Itzen M, Malick J, Babb JS, et al. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet 2003;119C (1):11-18.
25. Hughes C, Lerman C, Schwartz M, Peshkin BN, et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002;107 (2):143-150.
26. Miesfeldt S, Cohn WF, Jones SM, Ropka ME, et al. Breast cancer survivors' attitudes about communication of breast cancer risk to their children. Am J Med Genet C Semin Med Genet 2003;119(1):45-50.
27. MacDonald DJ, Choi J, Ferrell B, Sand S, et al. Concerns of women presenting to a comprehensive cancer center for genetic cancer risk assessment. J Med Genet 2002;39:526-530.
28. Lerman C, Croyle RT. Emotional and behavioral responses to genetic testing to cancer. Oncology 1996;19:191-199.
29. Tercyak KP, Hughes C, Main D, Snyder C, et al. Parental communication of BRCA1/2 genetic test results to children. Patient Educ Couns 2001;42:213-224.
30. Tercyak K, Peshkin B, DeMarco T, Brogan B, et al. Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns 2002;47(2):145.
31. Hughes C, Lynch H, Durham C, Snyder C, et al. Communication of BRCA1/2 test results in hereditary breast cancer families. Canc Res Ther Contr 1999;8:51-59.
32. Green J, Richards M, Murton F, Statham H, et al. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns 1997;6:45-60.
33. Patenaude AF, Dorval M, DiGianni LS, Schneider KA, et al. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006;24(4):700-706.
34. Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003;64(4):317-326.
35. Bastani R, Maxwell AE, Bradford C, Das IP, et al. Tailored risk notification for women with a family history of breast cancer. Prev Med 1999;29(5):355-364.
36. Giger J, Davidhizar R. Transcultural nursing: Assessment & intervention, 4th ed. St. Louis, MO: Mosby, 2004.
37. Loveland-Cherry CJ, Bomar PJ. Family health promotion and health protection. In: Bomar PJ, editors. Promoting health in families applying family research and theory to nursing practice, Vol. 3. Philadelphia: Saunders, 2004;61-89.
38. Sarna L, Tae YS, Kim YH, Brecht ML, et al. Cancer screening among Korean Americans. Cancer Pract 2001;9(3):134-140.
39. MacDonald DJ, Sarna L, Uman GC, Grant M, et al. Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment. Cancer Nurs 2005;28(5):372-379.
40. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-850.
41. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57(3):385-392.
42. Julian-Reynier C, Eisinger F, Vennin P, Chabal F, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet 1996;33(9):731-736.
43. MacDonald DJ, Sarna L, Uman GC, Grant M, et al. Cancer screening and risk reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers. Oncol Nurs Forum 2006;33(2):E27-35.
44. Daly MB, Axilbund JE, Bryant E, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 2006;4:156-176.
45. MacDonald DJ. Women's decisions regarding management of breast cancer risk. Medsurg Nurs 2002;11:183-186.
46. Manne S, Audrain J, Schwartz M, Main D, et al. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 2004;28(3):211-225.
47. Balmana J, Stoffel EM, Emmons KM, Garber JE, et al. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. J Med Genet 2004;41(4):e44.
48. Bonadona V, Saltel P, Desseigne F, Mignotte H, et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev 2002;11(1):97-104.
49. Smith KR, Zick CD, Mayer RN, Botkin JR. Voluntary disclosure of BRCA1 mutation test results. Genet Test 2002;6(2):89-92.